CWM LLC reduced its position in shares of HCP, Inc. (NYSE:HCP) by 2.0% during the second quarter, according to its most recent filing with the SEC. The fund owned 6,371 shares of the real estate investment trust’s stock after selling 129 shares during the period. CWM LLC’s holdings in HCP were worth $204,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Exane Derivatives boosted its position in HCP by 6.4% in the second quarter. Exane Derivatives now owns 43,504 shares of the real estate investment trust’s stock worth $1,390,000 after buying an additional 2,627 shares in the last quarter. Ronna Sue Cohen boosted its position in HCP by 1.0% in the second quarter. Ronna Sue Cohen now owns 58,581 shares of the real estate investment trust’s stock worth $1,872,000 after buying an additional 575 shares in the last quarter. BerganKDV Wealth Management LLC boosted its position in HCP by 7.4% in the second quarter. BerganKDV Wealth Management LLC now owns 50,350 shares of the real estate investment trust’s stock worth $1,609,000 after buying an additional 3,449 shares in the last quarter. Peoples Financial Services CORP. boosted its position in HCP by 4.0% in the second quarter. Peoples Financial Services CORP. now owns 3,250 shares of the real estate investment trust’s stock worth $104,000 after buying an additional 125 shares in the last quarter. Finally, Eqis Capital Management Inc. boosted its position in HCP by 7.7% in the second quarter. Eqis Capital Management Inc. now owns 14,048 shares of the real estate investment trust’s stock worth $449,000 after buying an additional 1,009 shares in the last quarter. Hedge funds and other institutional investors own 88.44% of the company’s stock.
HCP, Inc. (NYSE HCP) traded down 0.25% during midday trading on Friday, hitting $31.83. The stock had a trading volume of 3,144,336 shares. The company has a market cap of $14.91 billion, a P/E ratio of 19.41 and a beta of 0.37. The firm’s 50-day moving average price is $32.04 and its 200 day moving average price is $31.29. HCP, Inc. has a 12 month low of $27.61 and a 12 month high of $40.43.
HCP (NYSE:HCP) last issued its earnings results on Tuesday, May 2nd. The real estate investment trust reported $0.51 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.48 by $0.03. The company had revenue of $492.16 million during the quarter, compared to analyst estimates of $514.82 million. HCP had a return on equity of 12.39% and a net margin of 41.38%. The firm’s quarterly revenue was down 5.4% on a year-over-year basis. During the same quarter last year, the business posted $0.69 EPS. On average, analysts expect that HCP, Inc. will post $1.35 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, August 22nd. Investors of record on Monday, August 7th will be paid a $0.37 dividend. The ex-dividend date is Thursday, August 3rd. This represents a $1.48 dividend on an annualized basis and a yield of 4.65%. HCP’s dividend payout ratio (DPR) is 72.20%.
A number of research firms have issued reports on HCP. BidaskClub cut HCP from a “hold” rating to a “sell” rating in a research report on Thursday. Jefferies Group LLC restated a “hold” rating and set a $33.00 price target on shares of HCP in a report on Tuesday, July 25th. Goldman Sachs Group, Inc. (The) cut HCP from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $35.00 to $32.00 in a report on Monday, July 24th. Zacks Investment Research cut HCP from a “hold” rating to a “sell” rating in a report on Tuesday, July 18th. Finally, Stifel Nicolaus restated a “hold” rating and set a $31.00 price target on shares of HCP in a report on Friday, July 14th. Three analysts have rated the stock with a sell rating, fifteen have issued a hold rating and three have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $33.42.
In related news, insider Thomas Klaritch sold 2,651 shares of the firm’s stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $31.53, for a total value of $83,586.03. Following the completion of the transaction, the insider now owns 176,830 shares in the company, valued at approximately $5,575,449.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.22% of the company’s stock.
HCP Company Profile
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
